TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 131 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $19,000 | -64.2% | 39,821 | 0.0% | 0.00% | -66.7% |
| Q1 2019 | $53,000 | +17.8% | 39,821 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $45,000 | -59.1% | 39,821 | 0.0% | 0.01% | -50.0% |
| Q3 2018 | $110,000 | -97.9% | 39,821 | -94.2% | 0.01% | -94.9% |
| Q3 2015 | $5,163,000 | -87.8% | 692,036 | -22.5% | 0.24% | -86.6% |
| Q2 2015 | $42,368,000 | +91.0% | 893,076 | +47.5% | 1.77% | +109.9% |
| Q1 2015 | $22,182,000 | – | 605,393 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |